Sutro Biopharma (NASDAQ:STRO) Posts Quarterly Earnings Results, Misses Expectations By $0.14 EPS
Sutro Biopharma (NASDAQ:STRO) reported quarterly earnings that missed analysts' expectations, with a loss of $2.33 per share against an anticipated $2.19 loss and revenues of $9.84 million versus a forecast of $11.96 million. Following the announcement, the company's shares declined significantly. Despite the miss, …